SUPER HEALTH PHARMACY LLC NPI 1760836431

NPI Details

SUPER HEALTH PHARMACY LLC is a community/retail pharmacy pharmacy in Staten Island, NY. The provider is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes. SUPER HEALTH PHARMACY LLC NPI is 1760836431. The provider is registered as an organization entity type.
The provider Is Doing Business As Super Health Pharmacy.

The provider's business location address is:

6390 AMBOY RD
STATEN ISLAND, NY
ZIP 10309-155
Phone: (718) 967-4600
Fax: (718) 967-4601

The provider's authorized official is Mayank Parikh .
The authorized official title is Pharmacist and has the following contact phone number (718) 967-4600.

The CLIA number assigned to this NPI record is 33D2191315 - pharmacy with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc (HCPCS:U0002)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri (HCPCS:M0244)

The enumeration date for this NPI number is 4/19/2016 and was last updated on 5/28/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.